免疫性血小板减少性紫癜（ITP）脾切术临床疗效探讨

目的探讨不同类型免疫性血小板减少性紫癜经脾切术治疗后临床疗效，及腹腔镜下脾切除术的并发症。方法将32例免疫性血小板减少性紫癜患者采用脾切除术治疗，然后按照脾切除疗效标准进行疗效评价。结果32例免疫性血小板减少性紫癜患者采用脾切除术治疗后：总疗效较好15例46．9％、良好8例占25．0％、一般6例占18．8％、无效3例占9。4％。其中，激素无效型疗效较好与良好共8例占自身患者的80％，而激素依赖型疗效较好与良好共15例占自身患者的68．2％。结论腹腔镜下脾切除术是治疗激素依赖型与激素无效型ITP的有效方法，具有手术并发症发生率低和手术风险小等优点。

Immune thrombocytopenic purpura (ITP) clinical effects of splenectomy surgery

Objective To explore the different types of immune thrombocytopenic purpura after splenectomy in the treatment of clinical efficacy, and laparoscopic splenectomy complications. Methods 32 patients with immune thrombocytopenic purpura treated with splenectomy, and then follow splenectomy Evaluation of efficacy criteria. Results 32 patients with immune thrombocytopenic purpura treated by splenectomy after treatment: The total efficacy of 46.9% better in 15 cases, good in 8 cases accounted for 25.0%, accounting for 18.8% of the general 6 cases,3 cases accounted for 9.4%. Among them, hormone invalid type well and good efficacy accounted for a total of eight cases of their own 80% of patients,while the hormone-dependent efficacy well and good in 15 cases accounted for 68.2% of patients themselves. Conclusion Laparoscopic splenectomy is the treatment of steroid-dependent and hormone-based ITP invalid effective method, with a lower incidence of surgical complications and surgical risks of small-and so on.